These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1426024)

  • 21. Changes in vascular responsiveness to a thromboxane mimetic in endotoxin tolerance.
    Tempel GE; Brown AN; Morinelli TA; Halushka PV; Cook JA
    Shock; 2001 Nov; 16(5):389-92. PubMed ID: 11699079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
    Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
    J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
    Dorn GW
    J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboxane A2 receptors in equine monocytes: identification of a new subclass of TXA2 receptors.
    Simmons TR; Cook JA; Moore JN; Halushka PV
    J Leukoc Biol; 1993 Feb; 53(2):173-8. PubMed ID: 8383167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
    Webb ML; Liu EC; Monshizadegan H; Hedberg A; Misra RN; Goldenberg H; Harris DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1387-94. PubMed ID: 8450473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane A2 receptors are influenced by cell density in cultured rat aortic smooth muscle cells.
    Masuda A; Halushka PV
    Life Sci; 1991; 48(25):2391-5. PubMed ID: 1828517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human platelet aggregation and shape change are coupled to separate thromboxane A2-prostaglandin H2 receptors.
    Dorn GW; DeJesus A
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H327-34. PubMed ID: 1825455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocampal CA1 neurons.
    Hsu KS; Huang CC; Kan WM; Gean PW
    Am J Physiol; 1996 Oct; 271(4 Pt 1):C1269-77. PubMed ID: 8897834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.
    Senchyna M; Crankshaw DJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):262-70. PubMed ID: 8859002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
    Matsuda K; Mathur RS; Duzic E; Halushka PV
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations.
    Bowling N; Dubé GP; Kurtz WL; Brune KA; Saussy DL; Dorn GW; Mais DE
    J Mol Cell Cardiol; 1994 Jul; 26(7):915-23. PubMed ID: 7966360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of (5Z)-7-[3-endo-[(4-iodophenylsulfonyl) amino] -bicyclo[2.2.1]hep-2-exo-yl]heptenoic acid (IS-145) as an antagonist for the study of thromboxane A2 receptor.
    Kan WM; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jun; 48(6):439-45. PubMed ID: 8341721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP; Dorn GW; Rapoport RM
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
    Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
    Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
    Johnson GJ; Leis LA; Dunlop PC
    J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat.
    Morinelli TA; Tempel GE; Jaffa AA; Silva RH; Naka M; Folger W; Halushka PV
    Prostaglandins; 1993 May; 45(5):427-38. PubMed ID: 8321912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.